Xponance’s Acadia Pharmaceuticals ACAD Stock Holding History

Xponance’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$264K	Buy	11,870 +877	+8%	+$21K	﹤0.01%	1345
2025 Q4	$294K	Buy	10,993 +59	+0.5%	+$1.41K	﹤0.01%	1193
2025 Q3	$233K	Buy	10,934 +24	+0.2%	+$568	﹤0.01%	1283
2025 Q2	$235K	Sell	10,910 -675	-6%	-$12.5K	﹤0.01%	1249
2025 Q1	$192K	Buy	11,585 +1,434	+14%	+$26.1K	﹤0.01%	1280
2024 Q4	$186K	Buy	+10,151	New	+$164K	﹤0.01%	1304
2024 Q1	–	Sell	-9,552	Closed	-$299K	–	1312
2023 Q4	$299K	Buy	+9,552	New	+$228K	﹤0.01%	1065
2021 Q2	–	Sell	-11,827	Closed	-$305K	–	1248
2021 Q1	$305K	Buy	11,827 +216	+2%	+$9.51K	0.01%	958
2020 Q4	$621K	Buy	11,611 +44	+0.4%	+$2.18K	0.01%	647
2020 Q3	$477K	Buy	11,567 +338	+3%	+$14.6K	0.01%	662
2020 Q2	$544K	Buy	+11,229	New	+$539K	0.01%	562

Other funds holding ACAD

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return